Catalio Capital Management LP Makes New Investment in Billiontoone, Inc. $BLLN

Catalio Capital Management LP acquired a new position in shares of Billiontoone, Inc. (NASDAQ:BLLN) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 25,505 shares of the company’s stock, valued at approximately $2,087,000.

Other large investors also recently added to or reduced their stakes in the company. Rossby Financial LCC acquired a new position in Billiontoone during the fourth quarter worth $25,000. Wells Fargo & Company MN acquired a new position in Billiontoone during the fourth quarter worth $76,000. Smartleaf Asset Management LLC acquired a new position in Billiontoone during the fourth quarter worth $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in Billiontoone during the fourth quarter worth $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone during the fourth quarter worth $201,000.

Billiontoone Price Performance

Shares of NASDAQ BLLN opened at $99.38 on Thursday. The firm has a 50-day simple moving average of $89.23 and a 200-day simple moving average of $87.40. The stock has a market capitalization of $4.57 billion and a price-to-earnings ratio of 180.69. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18. Billiontoone, Inc. has a 52 week low of $61.96 and a 52 week high of $138.70.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.33. The firm had revenue of $108.39 million during the quarter, compared to analysts’ expectations of $95.81 million. During the same period in the prior year, the company posted ($0.39) EPS. The company’s revenue for the quarter was up 83.8% compared to the same quarter last year. On average, equities analysts predict that Billiontoone, Inc. will post 0.93 earnings per share for the current fiscal year.

Insider Transactions at Billiontoone

In related news, insider Bosch John Roderick Ten sold 2,832 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $101.47, for a total value of $287,363.04. Following the completion of the sale, the insider owned 34,968 shares of the company’s stock, valued at approximately $3,548,202.96. This represents a 7.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO David Tsao sold 20,000 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $102.27, for a total transaction of $2,045,400.00. Following the completion of the sale, the chief technology officer directly owned 1,000 shares of the company’s stock, valued at $102,270. This represents a 95.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 83,582 shares of company stock valued at $8,312,361 in the last three months.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on BLLN shares. Guggenheim increased their target price on shares of Billiontoone from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, May 13th. Weiss Ratings cut shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, June 5th. BTIG Research reduced their target price on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. JPMorgan Chase & Co. increased their target price on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Finally, Wells Fargo & Company reduced their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research report on Thursday, March 5th. Six research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Billiontoone currently has an average rating of “Moderate Buy” and a consensus target price of $125.29.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.